Cancer driven direct medical costs in Bangladesh: Evidence from patient perspective
- 22 February 2025
- journal article
- Published by Elsevier in Journal of Cancer Policy
- Vol. 43, 100565
Abstract
No abstract availableKeywords
Funding Information
- North South University
This publication has 21 references indexed in Scilit:
- Estimating surgery, radiotherapy and systemic anti-cancer therapy treatment costs for cancer patients by stage at diagnosisThe European Journal of Health Economics, 2023
- The cancer premium – explaining differences in prices for cancer vs non-cancer drugs with efficacy and epidemiological endpoints in the US, Germany, and Switzerland: a cross sectional studyeClinicalMedicine, 2023
- Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050JAMA Oncology, 2023
- Cancer will cost the world $25 trillion over next 30 yearsNature, 2023
- Financial Toxicity of Cancer TreatmentJAMA Oncology, 2022
- Cost of cancer management by stage at diagnosis among Medicare beneficiariesCurrent Medical Research and Opinion, 2022
- Assessing service availability and readiness to manage cervical cancer in BangladeshBMC Cancer, 2021
- Relationship between costs and clinical benefits of new cancer medicines in Australia, France, the UK, and the USSocial Science & Medicine, 2020
- The cost of cancer in Europe 2018European Journal of Cancer, 2020
- Pilot study assessing the direct medical cost of treating patients with cancer in Kenya; findings and implications for the futureJournal of Medical Economics, 2018